O. Yu. Sergunina
O. Yu. Sergunina has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Alexey V. Lyanguzov
Kirov Research Institute of Hematology and Blood Transfusion
3 shared publications - S. L. Kalinina
Kirov Research Institute of Hematology and Blood Transfusion
3 shared publications - S. V. Ignatyev
Kirov Research Institute of Hematology and Blood Transfusion
3 shared publications D. A. Dyakonov
Kirov Research Institute of Haematology and Blood Transfusion under the Federal Medicobiological Agency
1 shared publication- E. A. Vaskina
Kirov Research Institute of Hematology and Blood Transfusion, Federal Medical Biological Agency
1 shared publication - E. L. Nazarova
Kirov Research Institute of Hematology and Blood Transfusion of FMBA of Russia
1 shared publication
Latest Publications
- 22 October 2025
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 5,p. 74-80
Endothelial factors for prediction of mortality in blood cancer patients with sepsis
Objective. To investigate predictive capability of serum von Willebrand factor (VWF:Ag) and syndecan-1 (SDC-1) in blood cancer patients with sepsis. Material and methods. The study encompassed a cohort of 71 blood cancer patients with sepsis between 2020 and 2022. Disease severity and organ dysfunction were evaluated using the Acute Physiology and Chronic Health Evaluation II (APACHE II), Simplified Acute Physiology Score II (SAPS II), and Sepsis-related Organ Failure Assessment (SOFA) scoring systems. Prognostic value of SDC-1 and VWF:Ag concentrations in predicting mortality was assessed. Results. The mortality rate was 39.4%. Comparative analysis of SDC-1 and VWF:Ag concentrations in patients with different outcomes revealed significantly higher concentrations of SDC-1 (Mann-Whitney U=217.0; p<0.001) and VWF:Ag (Mann-Whitney U=268.5; p<0.001) in dead patients. No significant differences were observed in procalcitonin and C-reactive protein (CRP) concentrations between survivors and non-survivors. Positive correlations were demonstrated between SDC-1 concentrations and SOFA scores (Spearman’s rho=0.338, p=0.004), as well as APACHE II scores (Spearman’s rho=0.346; p=0.003). Similarly, positive correlations were observed between VWF:Ag concentrations and APACHE II scores (Spearman’s rho=0.296; p=0.012), as well as APACHE II scores (Spearman’s rho=0.272, p=0.022). Survival analysis revealed significant differences in outcomes between patients with SDC-1 concentrations greater and less than the median (14 ng/ml) (log-rank χ2=5.77, p=0.016) and VWF:Ag concentrations greater and less than the median (383%) (log-rank χ2=11.74; p=0.0006). Multivariate analysis demonstrated a significant association between SDC-1 (OR=1.052; 95% CI 1.020—1.084; p=0.001) and VWF:Ag (OR=1.005; 95% CI 1.001—1.009; p=0.011) concentrations with mortality. Conclusion. SDC-1 and VWF:Ag concentrations may be potential biomarkers for predicting mortality in blood cancer patients with sepsis.
- 22 October 2025
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 5,p. 74-80
Endothelial factors for prediction of mortality in blood cancer patients with sepsis
Objective. To investigate predictive capability of serum von Willebrand factor (VWF:Ag) and syndecan-1 (SDC-1) in blood cancer patients with sepsis. Material and methods. The study encompassed a cohort of 71 blood cancer patients with sepsis between 2020 and 2022. Disease severity and organ dysfunction were evaluated using the Acute Physiology and Chronic Health Evaluation II (APACHE II), Simplified Acute Physiology Score II (SAPS II), and Sepsis-related Organ Failure Assessment (SOFA) scoring systems. Prognostic value of SDC-1 and VWF:Ag concentrations in predicting mortality was assessed. Results. The mortality rate was 39.4%. Comparative analysis of SDC-1 and VWF:Ag concentrations in patients with different outcomes revealed significantly higher concentrations of SDC-1 (Mann-Whitney U=217.0; p<0.001) and VWF:Ag (Mann-Whitney U=268.5; p<0.001) in dead patients. No significant differences were observed in procalcitonin and C-reactive protein (CRP) concentrations between survivors and non-survivors. Positive correlations were demonstrated between SDC-1 concentrations and SOFA scores (Spearman’s rho=0.338, p=0.004), as well as APACHE II scores (Spearman’s rho=0.346; p=0.003). Similarly, positive correlations were observed between VWF:Ag concentrations and APACHE II scores (Spearman’s rho=0.296; p=0.012), as well as APACHE II scores (Spearman’s rho=0.272, p=0.022). Survival analysis revealed significant differences in outcomes between patients with SDC-1 concentrations greater and less than the median (14 ng/ml) (log-rank χ2=5.77, p=0.016) and VWF:Ag concentrations greater and less than the median (383%) (log-rank χ2=11.74; p=0.0006). Multivariate analysis demonstrated a significant association between SDC-1 (OR=1.052; 95% CI 1.020—1.084; p=0.001) and VWF:Ag (OR=1.005; 95% CI 1.001—1.009; p=0.011) concentrations with mortality. Conclusion. SDC-1 and VWF:Ag concentrations may be potential biomarkers for predicting mortality in blood cancer patients with sepsis.
- Open Access
- 4 July 2020
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 7 (2) , 35-41
Use of totally implantable venous port systems in children hematology clinic
Relevance.Reliable and long-term venous access is one of the most important condition for a successful leukemia therapy in children. Safe and convenient access to a central vein allows to provide chemotherapy, adjuvant treatment, parenteral nutrition and blood transfusion. It decreases the likelihood of phlebitis development and reduction of the peripheral venous network in comparison with peripheral venous access. The use of totally implantable venous port systems reduces risks of severe complications associated with re-catheterization of the central vein thus it improves patient’s quality of life.The purpose of the studyis a retrospective assessment of the experience of use and analysis of the complications of totally implantable venous port systems in children with diseases of the blood system.Materials and methods.The data of 61 patients of the pediatric hematology clinic with venous port systems have been analyzed.Results.Perioperative complications developed in 3 (4.9 %) patients Median time of using of port systems was 679 catheter-days. Delayed complications requiring removal of the device developed in 8 (13.1 %) patients. Infectious complications were the reason for device removal in 3 (2.9 %) patients, mechanical complications in 5 (8.2 %) patients. No thrombotic complications were found.Conclusions.The use of venous port systems in children with hematologic diseases for a long period of time is an effective and safe way for central venous access providing.
- 4 July 2020
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 7 (2) , 35-41
Open AccessUse of totally implantable venous port systems in children hematology clinic
Relevance.Reliable and long-term venous access is one of the most important condition for a successful leukemia therapy in children. Safe and convenient access to a central vein allows to provide chemotherapy, adjuvant treatment, parenteral nutrition and blood transfusion. It decreases the likelihood of phlebitis development and reduction of the peripheral venous network in comparison with peripheral venous access. The use of totally implantable venous port systems reduces risks of severe complications associated with re-catheterization of the central vein thus it improves patient’s quality of life.The purpose of the studyis a retrospective assessment of the experience of use and analysis of the complications of totally implantable venous port systems in children with diseases of the blood system.Materials and methods.The data of 61 patients of the pediatric hematology clinic with venous port systems have been analyzed.Results.Perioperative complications developed in 3 (4.9 %) patients Median time of using of port systems was 679 catheter-days. Delayed complications requiring removal of the device developed in 8 (13.1 %) patients. Infectious complications were the reason for device removal in 3 (2.9 %) patients, mechanical complications in 5 (8.2 %) patients. No thrombotic complications were found.Conclusions.The use of venous port systems in children with hematologic diseases for a long period of time is an effective and safe way for central venous access providing.
- Open Access
- 25 July 2019
- Published by Publishing House ABV Press in Oncohematology
- Vol. 14 (2)
Extramedular lesions of a small intestinum in acute myeloid leukemia: case report and literature review
Currently, the diagnosis of acute myeloid lekemia is based on the standards of morphological studies and immunophenotyping of the bone marrow. The manifestation of the disease can be accompanied by extramedullary lesions, which are difficult to verify. The article presents a case of diagnosis of acute myeloid lekemia in an elderly w oman, occurring with a leukemic lesion of the small in - testine. Morphological studies and immunophenotyping of small intestine biopsy revealed acute myeloid lekemia blast tumor cells. Difficulties of examination in such cases lead to late revealing of leukemic infiltrates of rare localization and significantly worsen the prognosis.
- 25 July 2019
- Published by Publishing House ABV Press in Oncohematology
- Vol. 14 (2)
Open AccessExtramedular lesions of a small intestinum in acute myeloid leukemia: case report and literature review
Currently, the diagnosis of acute myeloid lekemia is based on the standards of morphological studies and immunophenotyping of the bone marrow. The manifestation of the disease can be accompanied by extramedullary lesions, which are difficult to verify. The article presents a case of diagnosis of acute myeloid lekemia in an elderly w oman, occurring with a leukemic lesion of the small in - testine. Morphological studies and immunophenotyping of small intestine biopsy revealed acute myeloid lekemia blast tumor cells. Difficulties of examination in such cases lead to late revealing of leukemic infiltrates of rare localization and significantly worsen the prognosis.